Introduction: We investigated whether pacing-induced electrical dyssynchrony at the time of cardiac resynchronization therapy (CRT) device implantation was associated with chronic CRT response. Methods and Results: We included a total of 69 consecutive heart failure patients who received a CRT device. Left (LVp-RVs) and right (RVp-LVs) pacing-induced interlead delays were measured intraoperatively and used to determine if there was paced left ventricular (LV) dyssynchrony, defined as present when LVp-RVs is larger than RVp-LVs. CRT response was defined as a reduction in LV end-systolic volume ≥15%, 6 months after implantation. Paced left ventricular dyssynchrony (PLVD) was associated with ischemic cardiomyopathy (ICM) (χ 2: 8; P =.005) but ...
BackgroundCardiac Resynchronization Therapy (CRT) is associated with reverse left ventricular (LV) r...
Aims: Despite continuous efforts in improving the selection process, the rate of non-responders to c...
International audienceBACKGROUND: For patients with symptomatic New York Heart Association class III...
Introduction: We investigated whether pacing-induced electrical dyssynchrony at the time of cardiac ...
We investigated whether pacing-induced electrical dyssynchrony at the time of cardiac resynchronizat...
Background: Electrocardiographic mapping (ECM) expresses electrical substrate through magnitude and ...
BackgroundThe mechanisms of action of cardiac resynchronisation therapy (CRT) and the predictive fac...
Aims Chronic right ventricular (RV) pacing may impose ventricular dyssynchrony leading to LV remodel...
BACKGROUND: The predictive value of interventricular versus intraventricular dyssynchrony for respon...
AbstractBackgroundLeft ventricular dyssynchrony plays an important role in predicting response to ca...
Cardiac resynchronization therapy (CRT) is an important therapy for heart failure patients with prol...
Background: The presence of viable myocardium may predict response to cardiac resynchronization ther...
Aims Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in systolic heart failu...
Background: Pronounced echocardiographically measured mechanical dyssynchrony is a positive predicto...
Even with the remarkable results of cardiac resynchronization therapy (CRT) in the large randomized ...
BackgroundCardiac Resynchronization Therapy (CRT) is associated with reverse left ventricular (LV) r...
Aims: Despite continuous efforts in improving the selection process, the rate of non-responders to c...
International audienceBACKGROUND: For patients with symptomatic New York Heart Association class III...
Introduction: We investigated whether pacing-induced electrical dyssynchrony at the time of cardiac ...
We investigated whether pacing-induced electrical dyssynchrony at the time of cardiac resynchronizat...
Background: Electrocardiographic mapping (ECM) expresses electrical substrate through magnitude and ...
BackgroundThe mechanisms of action of cardiac resynchronisation therapy (CRT) and the predictive fac...
Aims Chronic right ventricular (RV) pacing may impose ventricular dyssynchrony leading to LV remodel...
BACKGROUND: The predictive value of interventricular versus intraventricular dyssynchrony for respon...
AbstractBackgroundLeft ventricular dyssynchrony plays an important role in predicting response to ca...
Cardiac resynchronization therapy (CRT) is an important therapy for heart failure patients with prol...
Background: The presence of viable myocardium may predict response to cardiac resynchronization ther...
Aims Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in systolic heart failu...
Background: Pronounced echocardiographically measured mechanical dyssynchrony is a positive predicto...
Even with the remarkable results of cardiac resynchronization therapy (CRT) in the large randomized ...
BackgroundCardiac Resynchronization Therapy (CRT) is associated with reverse left ventricular (LV) r...
Aims: Despite continuous efforts in improving the selection process, the rate of non-responders to c...
International audienceBACKGROUND: For patients with symptomatic New York Heart Association class III...